Endexx Corp Stock Price, News & Analysis

Endexx Corporation (OTC:EDXC) announced record sales with its HYLA division showcasing innovative non-nicotine vape products at the CHAMPS show in Las Vegas, from February 8-11, 2023. HYLA has generated over $3 million in revenue and has outstanding purchase orders of $3 million, projecting revenues exceeding $10 million for 2023, a tenfold increase from 2022. CEO Todd Davis noted the expected 2-3 years of exponential growth for HYLA products as they cater to a market moving away from nicotine-based options. This trade show represents significant market exposure for the brand.

Endexx Corporation (OTC: EDXC) reported a significant 96% increase in top-line revenue for fiscal 2022, achieving $503,009 in gross profit compared to a loss of $344,078 the previous year. The company successfully reduced operating expenses by 23% ($1,162,007). Key milestones included launching a Men’s Skincare and Grooming line in national retailers like Target and CVS, growing retail presence from 4,000 to over 8,000 stores, and acquiring a 51% interest in HYLA™, specializing in plant-based vape products. CEO Todd Davis anticipates continued revenue growth and market expansion into fiscal 2024 and 2025.

Endexx Corporation (OTC:EDXC) has successfully shipped over $3 million of its $6 million in HYLA non-nicotine vape product orders to 11 countries since October 2022. This includes a crucial half of a $3.8 million order that has cleared Italian customs, marking approval in Italy. The company anticipates growing demand for HYLA due to its unique non-nicotine formula and aims to penetrate other markets facing nicotine product regulations. Endexx believes this innovative product will establish itself as a revolutionary alternative in the vape market.

Endexx Corporation (OTC: EDXC) announced its virtual presentation at the Sequire Virtual Small Cap Conference on December 8, 2022, at 1:00 PM EST. CEO Todd Davis highlighted the company's growth, expanding to over 8,000 retailers and achieving over $6 million in sales from the HYLA acquisition within two months. Endexx is focused on sustainable, plant-based health and skincare products, aiming for significant revenue growth in 2023. The event will feature multiple companies in the small-cap sector.

Endexx Corporation (OTC:EDXC) reports over $6 million in revenue in the first sixty days of its fiscal quarter, surpassing its previous annual revenue by more than 500%. This increase is attributed to the HYLA acquisition and heightened demand for their CBD pain products and men's skincare line, now selling in 13 countries. The products are available in major retailers, including Amazon and Walgreens. CEO Todd Davis emphasizes the ongoing benefits from HYLA's distribution network, expecting continued growth and new opportunities in upcoming quarters.

Endexx Corporation (OTC:EDXC) announced a new $3.8 million order for its non-nicotine vape product, HYLA, from Italian customers, contributing to a revenue of approximately $6 million in the first two fiscal quarters of 2023. This revenue significantly surpasses the total for the entire previous year. The order indicates strong market demand and enhances the company’s strategic reach in influential regions, particularly eastward from Italy. CEO Todd Davis highlighted positive market dynamics and the successful reception of HYLA, driven by its natural ingredients.

Endexx Corporation (OTC: EDXC) has announced securing $2.3 million in purchase orders for its non-nicotine plant-based vape product, HYLA™, within just 55 days post-acquisition. The orders, coming from the Western US, a Central Asian nation, and Dubai, are expected to generate approximately $827,000 and $1.5 million in revenue, respectively. The Dubai order spans six months, hinting at potential growth. CEO Todd Davis expressed optimism about recouping HYLA's acquisition costs by the second quarter and enhancing overall revenue.

Endexx Corporation (OTC:EDXC) has announced its expansion into hemp distribution across four states: Louisiana, Alaska, Texas, and Iowa. Securing authorization in Louisiana, known for its strict requirements, marks a significant milestone for the company. CEO Todd Davis highlighted the company's ongoing efforts to meet compliance requirements in all 50 states while keeping abreast of federal changes. Endexx specializes in innovative health and skincare products derived from plants, developed through extensive clinical research to promote skin health.

Endexx Corporation (OTC:EDXC) reports significant progress in marketing and distribution, enhancing its position for a strong fiscal 2023. The company has expanded its Blesswell™ skincare line into over 8,000 retail stores, including Target and Amazon, and increased its international presence to 13 countries. The acquisition of HYLA adds a non-nicotine, guarana-based vape product to its offerings, facilitating further distribution growth. Additionally, Endexx improved its balance sheet by replacing convertible debt with a non-convertible debt facility. The company secured over 200,000 new purchase orders in its first month post-acquisition.